Navigation Links
Cambrex Reports Third Quarter 2009 Results
Date:11/3/2009

EAST RUTHERFORD, N.J., Nov. 3 /PRNewswire-FirstCall/ --Cambrex Corporation (NYSE: CBM) reports third quarter results for the period ended September 30, 2009.

Highlights

  • Sales increased 6.1% compared to third quarter 2008 excluding the impact of foreign currency. Reported sales increased by 2.3% for the quarter.
  • EBITDA was $11.0 million in the third quarter 2009 compared to Adjusted EBITDA of $11.4 million in the same quarter last year (see following table).
  • Debt, net of cash was $78.7 million at the end of third quarter 2009, a $4.3 million improvement during the quarter.
  • Net income was $3.0 million compared with Net income of $2.8 million for the third quarter of 2008.

Third Quarter 2009 Operating Results

Third quarter 2009 sales of $57.8 million were 2.3% higher than the third quarter 2008. Excluding a 3.8% unfavorable impact of foreign exchange, reflecting a stronger U.S. dollar, sales increased 6.1%. The increase is primarily due to higher volumes of an active pharmaceutical ingredient ("API") that utilizes the Company's polymeric drug delivery technology, increased generic revenues resulting from the timing of orders and higher controlled substances and custom development revenues. Partially offsetting these increases were lower sales of two APIs manufactured under long-term supply agreements and a feed additive for which a contract expired earlier in 2009.

Third quarter 2009 Gross Margin increased to 29.3% of sales from 28.7% during the third quarter 2008, with foreign currency unfavorably impacting gross margin by 2.7%. Cost reductions, and to a lesser extent, positive product mix, were the main drivers of the higher margins. This was partially offset by lower pricing of generic APIs and an API manufactured under a lo
'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Medical researchers with EDP Biotech Corporation (EDP) ... technology for a simple blood test to detect ... success of its pre-clinical trials for the ColoMarker(TM) ... biomarker, CA11-19, and all aspects of its use. ... detect colon cancer in its earliest, most curable ...
(Date:12/15/2009)... Dec. 15 Certified healthcare providers who ... complications from the H1N1 flu virus may now ... the Department of Health announced today. ,, ... everyone because approximately 3.2 million doses of vaccine ... it to individuals in the priority groups. ,, ...
(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Are the monoamines involved in shaping conduct disorders 3F 9898 1Are the monoamines involved in shaping conduct disorders 3F 9898 2Are the monoamines involved in shaping conduct disorders 3F 9898 3Are the monoamines involved in shaping conduct disorders 3F 9898 4Are the monoamines involved in shaping conduct disorders 3F 9898 5Are the monoamines involved in shaping conduct disorders 3F 9898 6Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 1Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 2Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 3Hormone promises to keep joint injuries from causing long term osteoarthritis 56985 4For Organ Donation Intent and Reality Dont Align 56981 1For Organ Donation Intent and Reality Dont Align 56981 2For Organ Donation Intent and Reality Dont Align 56981 3
... Menopause Society 19th Annual ... Meeting, ... present an abstract in a presentation on their new drug,candidate, VG101, for ... American Menopause Society in Orlando, Florida on,September 26, 2008. Dr. Mary Tagliaferri, ...
... LAUSANNE, Switzerland, September 25 Debiopharm Group,(Debiopharm), ... serious medical conditions and particularly oncology, announces,the ... Agencies for the approval of,its new 6-month ... luteinizing hormone releasing hormone (LHRH) agonist for ...
Other Medicine Technology:Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 3Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients 2
(Date:12/15/2009)... Authority, Ban on Annual Benefit Limits, & Effective ... -- Consumer Watchdog condemned the removal of the ... the public option from the U.S. Senate health ... Senate must still make three essential fixes to ... entire health care system to the insurance industry. ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security company, today ... Series next-generation firewalls for accurate threat prevention on ... control over applications such as peer-to-peer file sharing. ... with eight facilities on five campuses. The university ... of academic schools and institutions throughout Japan. It ...
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... CDC have released some sobering statistics concerning the parallel rise in ... employers an effective means of combating this trend afflicting their workforce. ... ... Rates of diabetes are climbing across America due in large part ... the American Diabetes Association has stated that the rate of diabetes ...
Breaking Medicine News(10 mins):Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3
... Pharmaceutical product teams,have the power to make ... The problem is,launch teams often lack the right ... only produce a sub-optimal launch. In fact, ... and cross-functional team work are key ingredients,during product ...
... Advancement of Novel Technology and ... Product Portfolio, ... therapeutic antibody product company, today announced that,it has raised $33.9 million ... participating significantly in the round were Frazier,Healthcare Ventures and Alloy Ventures, ...
... CHICO, Calif., Nov. 8 State,Compensation Insurance Fund ... part of State Fund,s Employer Education Series, featuring ... Back,Connection(TM). The three-hour seminar entitled "Watch Your Back",introduces ... how they,can involve the very people they are ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... drugs for the treatment of,diabetes and cardio-metabolic diseases, ... the company as Chief Medical Officer. Dr. DePaoli,will ... and will be,responsible for the clinical development of ...
... $7.5 Million in 2008, OTTAWA, Canada, ... Natural Nutrition press release is, http://www.naturalnutritioninc.com . ... (OTC Bulletin Board: NNTN), http://www.naturalnutritioninc.com has ... adding state-of-the-art equipment to produce,sheeted protein and ...
... On November 9, the,Department of Veterans Affairs ... award one contract to conduct two important technical ... the updating of our military,disability system. The studies ... on Care for America,s Returning Wounded Warriors,co-chaired by ...
Other Medicine News:Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 2Health News:Pharmaceutical Product Commercialization: Enabling Teams to Excel 3Health News:Anaptys Biosciences Raises Over $33 Million in Series B Financing 2Health News:Anaptys Biosciences Raises Over $33 Million in Series B Financing 3Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 2Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 3Health News:InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer 2Health News:InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer 3Health News:Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line 2Health News:Modernizing and Improving the Disability and Compensation Systems 2Health News:Modernizing and Improving the Disability and Compensation Systems 3
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
Skull Traction Tongs for cervical vertebra extension, adjustable pins, eliminates need for preliminary drilling, large pattern, complete with wrench...
Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...
Medicine Products: